Abstract:The financial viability of a cell and tissue-engineered therapy may depend on the compatibility of the therapy with mass production and cryopreservation. Herein, we developed a method for the mass production and cryopreservation of 3D cartilage microtissues. Cartilage microtissues were assembled from either 5000 human bone marrow-derived stromal cells (BMSC) or 5000 human articular chondrocytes (ACh) each using a customized microwell platform (the Microwell-mesh). Microtissues rapidly accumulate homogenous cartilage-like extracellular matrix (ECM), making them potentially useful building blocks for cartilage defect repair. Cartilage microtissues were cultured for 5 or 10 days and then cryopreserved in 90% serum plus 10% dimethylsulfoxide (DMSO) or commercial serum-free cryopreservation media. Cell viability was maximized during thawing by incremental dilution of serum to reduce oncotic shock, followed by washing and further culture in serum-free medium. When assessed with live/dead viability dyes, thawed microtissues demonstrated high viability but reduced immediate metabolic activity relative to unfrozen control microtissues. To further assess the functionality of the freeze-thawed microtissues, their capacity to amalgamate into a continuous tissue was assess over a 14 day culture. The amalgamation of microtissues cultured for 5 days was superior to those that had been cultured for 10 days. Critically, the capacity of cryopreserved microtissues to amalgamate into a continuous tissue in a subsequent 14-day culture was not compromised, suggesting that cryopreserved microtissues could amalgamate within a cartilage defect site. The quality ECM was superior when amalgamation was performed in a 2% O2 atmosphere than a 20% O2 atmosphere, suggesting that this process may benefit from the limited oxygen microenvironment within a joint. In summary, cryopreservation of cartilage microtissues is a viable option, and this manipulation can be performed without compromising tissue function.

Cryopreservation of Cells in 3D Constructs Based on Controlled Cell Assembly Processes

A PROPOSED DESIGN FOR THE CRYOPRESERVATION OF INTACT AND ADHERENT HUMAN EMBRYONIC STEM CELL COLONIES

Cryopreservation of Cell/hydrogel Constructs Based on a New Cell-Assembling Technique

Cryopreservation method for spheroids and fabrication of scaffold-free tubular constructs

Rapid Prototyping of Tubular Polyurethane and Cell/Hydrogel Constructs

Incorporation of DMSO and Dextran-40 into a Gelatin/alginate Hydrogel for Controlled Assembled Cell Cryopreservation.

Coexisting with Ice Crystals: Cryogenic Preservation of Muscle Food-Mechanisms, Challenges, and Cutting-Edge Strategies

Effect of 'in air' freezing on post-thaw recovery of Callithrix jacchus mesenchymal stromal cells and properties of 3D collagen-hydroxyapatite scaffolds

Chemically Induced Extracellular Ice Nucleation Reduces Intracellular Ice Formation Enabling 2D and 3D Cellular Cryopreservation

DeepFreeze 3D‐biofabrication for Bioengineering and Storage of Stem Cells in Thick and Large‐Scale Human Tissue Analogs

Cryopreservation Engineering Strategies for Mass Production of Adipose-Derived Stem Cells

Cryopreserved cell-laden alginate microgel bioink for 3D bioprinting of living tissues

Extracellular Matrix-Mimetic Peptide Scaffolds Prolonged the Hypothermic Preservation of Stem Cells for Storage and Transportation

Alginate Functionalized Biomimetic 3D Scaffold Improves Cell Culture and Cryopreservation for Cellular Therapy.

Freeform cell-laden cryobioprinting for shelf-ready tissue fabrication and storage

Biofabrication & cryopreservation of tissue engineered constructs for on-demand applications

Specifics of Cryopreservation of Hydrogel Biopolymer Scaffolds with Encapsulated Mesenchymal Stem Cells

Method for manufacture and cryopreservation of cartilage microtissues

Slow Cooling Cryopreservation of Cell-Microcarrier Constructs

Paper-based cell cryopreservation